Loading…
Elanco Animal Health Incorporated is projected to rise to $27.93 by 2027, a +13% move from its current price of $24.82. ELAN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $24.30 | $24.83 | $25.37 | +0.03% |
| Jul 14 | $24.09 | $24.84 | $25.61 | +0.07% |
| Jul 15 | $23.93 | $24.85 | $25.80 | +0.10% |
| Jul 16 | $23.80 | $24.85 | $25.95 | +0.14% |
| Jul 17 | $23.69 | $24.86 | $26.10 | +0.17% |
| Jul 18 | $23.58 | $24.87 | $26.23 | +0.20% |
| Jul 19 | $23.49 | $24.88 | $26.35 | +0.24% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $23.49 | $24.88 | $26.35 | +0.24% |
| Week 2 | $23.00 | $24.94 | $27.05 | +0.48% |
| Week 3 | $22.63 | $25.00 | $27.61 | +0.72% |
| Week 4 | $22.34 | $25.06 | $28.10 | +0.96% |
| Week 5 | $22.10 | $25.12 | $28.55 | +1.20% |
| Week 6 | $21.88 | $25.18 | $28.97 | +1.44% |
| Week 7 | $21.69 | $25.24 | $29.37 | +1.68% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Elanco Animal Health Incorporated is an animal health company that develops, manufactures, and markets products for pets and farm animals worldwide. Its portfolio includes pet health products such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines and therapeutics for pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark.
The company also provides farm animal products to help farmers improve animal health and wellbeing and raise livestock, such as medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax trademarks.
The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.
Elanco Animal Health Incorporated (ELAN) is a healthcare company operating in the animal health space. The stock is currently priced at $24.57 per share and has a market capitalization of $12.27B, with a market rank of 822.
From the listed forecasts, the price trajectory shows upside over the coming years, starting from an average of $24.57 in 2026 and rising to $35.07 by 2030, then continuing higher to $164.77 by 2050. The implied path suggests meaningful longer-term upside with increasing averages as the horizon extends.
A major floor 20.2% below — a decisive break under it would weaken the trend.
The nearest floor, 7.9% below — buyers have tended to step in here.
Price is pressing into resistance (1.2% away) — a breakout level to watch.
A major ceiling 6.9% above — clearing it would confirm fresh momentum.
Key ELAN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ELAN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $24.78 | Buy | $24.72 | Buy |
| MA 10 | $24.69 | Buy | $24.61 | Buy |
| MA 20 | $24.33 | Buy | $24.33 | Buy |
| MA 50 | $23.37 | Buy | $23.82 | Buy |
| MA 100 | $23.69 | Buy | $23.45 | Buy |
| MA 200 | $23.03 | Buy | $22.18 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.96 | Neutral |
| Stoch RSI (14) | 73.40 | Neutral |
| CCI (20) | 84.13 | Neutral |
| Williams %R (14) | -15.90 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | 7.08 | Buy |
| Bollinger %B (20,2) | 0.75 | Neutral |
| Stochastic %K (14) | 84.10 | Sell |
| TRIX (15) | 0.24 | Buy |
| Awesome (5,34) | 0.80 | Buy |
| Ultimate (7,14,28) | 54.74 | Neutral |
| Momentum (10) | 0.45 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 24.73 | Buy |
| ADX (14) | 11.32 | Neutral |
| ATR (14) | 0.43 | Info |
The 30-day technical picture is bullish, with RSI(14) at 60. The stock trades above the 50-day simple moving average of $23.02 and above the 200-day simple moving average of $22.76, indicating a positive near-term trend.
Near-term support is at $19.80 and resistance at $24.71. The 30-day price range runs from $20.65 to $29.24, and the current price is $24.57, placing it near the key near-term resistance level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.80 | $24.82 | $31.78 | 0% | Neutral | |
| $22.66 | $27.93 | $36.15 | +13% | Neutral | |
| $23.19 | $29.20 | $38.95 | +18% | Neutral | |
| $25.58 | $32.80 | $44.80 | +32% | Bullish | |
| $27.69 | $36.07 | $50.26 | +45% | Bullish | |
| $32.85 | $43.40 | $61.56 | +75% | Bullish | |
| $37.29 | $49.92 | $71.94 | +101% | Bullish | |
| $37.32 | $50.58 | $73.94 | +104% | Bullish | |
| $38.97 | $53.43 | $79.16 | +115% | Bullish | |
| $41.27 | $57.22 | $85.83 | +131% | Bullish | |
| $60.96 | $88.84 | $140.39 | +258% | Bullish | |
| $103.99 | $164.82 | $281.26 | +564% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $19.80 | $24.82 | $29.32 | +0.00% |
| August 2026 | $21.40 | $25.12 | $30.18 | +1.22% |
| September 2026 | $21.69 | $25.60 | $31.03 | +1.91% |
| October 2026 | $21.33 | $25.29 | $30.88 | -1.22% |
| November 2026 | $21.07 | $25.09 | $30.83 | -0.80% |
| December 2026 | $21.52 | $25.71 | $31.78 | +2.50% |
Click any year to see its month-by-month ELAN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ELAN could reach as high as $31.78, with a base case around $24.82 and support toward $19.80 — roughly 0% from $24.82. A consolidation phase looks the most probable path here.
Expect ELAN to range from $22.66 to $36.15 through 2027. The $27.93 average target implies a +13% move from current prices. That is up +13% on the projected 2026 average. Price action looks broadly range-bound.
The ELAN price prediction for 2028 points to an average of $29.20 (low $23.19, high $38.95) — a potential gain of +18% on today's $24.82. A consolidation phase looks the most probable path here.
In 2029, ELAN is projected to trade between $25.58 and $44.80, averaging $32.80 — a potential gain of +32% from today's $24.82. That is up +12% on the projected 2028 average. Momentum favours further upside here.
Elanco Animal Health Incorporated's 2030 outlook centres on $36.07, within a $27.69 to $50.26 range. That is up +10% on the projected 2029 average. That marks a +45% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, ELAN could reach as high as $61.56, with a base case around $43.40 and support toward $32.85 — roughly +75% from $24.82. Momentum favours further upside here.
Expect ELAN to range from $37.29 to $71.94 through 2032. The $49.92 average target implies a +101% move from current prices. That is up +15% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The ELAN price prediction for 2033 points to an average of $50.58 (low $37.32, high $73.94) — a potential gain of +104% on today's $24.82. Momentum favours further upside here.
In 2034, ELAN is projected to trade between $38.97 and $79.16, averaging $53.43 — a potential gain of +115% from today's $24.82. That is up +6% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Elanco Animal Health Incorporated's 2035 outlook centres on $57.22, within a $41.27 to $85.83 range. That is up +7% on the projected 2034 average. That marks a +131% change versus current levels. Momentum favours further upside here.
By 2040, ELAN could reach as high as $140.39, with a base case around $88.84 and support toward $60.96 — roughly +258% from $24.82. Buyers look set to stay in control over this stretch.
Expect ELAN to range from $103.99 to $281.26 through 2050. The $164.82 average target implies a +564% move from current prices. That is up +86% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ELAN today (≈ 40.290089 ELAN) could be worth
$6,640.69
+$5,640.69 (+564%) by 2050 · US Dollar
Based on the average projected ELAN price of $164.82 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ELANwould be worth at today's price.
$1,000 invested in ELAN on Jul 10, 2025 (≈ 66.489362 ELAN) would be worth
$1,650.27
+$650.27 (+65.0%) today · 1.65× · US Dollar
Based on a ELAN entry price of $15.04 vs. today's $24.82.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $25 | $992.8 | -0.7% |
| 1 month ago | $22.87 | $1,085.26 | +8.5% |
| 3 months ago | $23.13 | $1,073.07 | +7.3% |
| 6 months ago | $23.87 | $1,039.8 | +4.0% |
| 1 year ago | $15.04 | $1,650.27 | +65.0% |
| All time (5.0y) ago | $34.22 | $725.31 | -27.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ELAN forecast.
Our base-case forecast reaches $50.00 around 2033.
Implied market cap at $50.00: $24.97B
The multi-year forecast shows a bullish trajectory with rising averages and substantial upside over time. In 2027 the average is $27.32 with an ROI of 11.2%; in 2028 the average is $28.36 with an ROI of 15.4%; in 2029 the average is $32.16 with an ROI of 30.9%; and in 2030 the average is $35.07 with an ROI of 42.7%.
Looking further out, 2040 yields an average of $88.86 with a max of $148.60 and an ROI of 261.7%, while 2050 shows an average of $164.77 with a max of $300.82 and an ROI of 570.6%.
These are estimates and not guarantees; actual results may vary with market conditions and other factors.
Tap a question to reveal the answer.
Avg $35.07; min $26.13; max $50.70; ROI 42.7%; sentiment BULLISH.
Forecasts show bullish sentiment in later years with rising averages: 2029 avg $32.16 (ROI 30.9%), 2030 avg $35.07 (ROI 42.7%), 2050 avg $164.77 (ROI 570.6%). These are estimates, not guarantees.
Yes. The forecast shows a 2040 max of $148.60, which exceeds $100.
Avg $24.57; min $19.80; max $32.23; ROI 0%; sentiment NEUTRAL.
By 2050, the avg is $164.77 with a max of $300.82, min $95.36 and ROI 570.6%; sentiment BULLISH.
Elanco Animal Health Incorporated Community Discussion
0Share your Elanco Animal Health Incorporated price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.